Related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES
Monday 19 November 2012
  • APEX Medical
  • Performance
    The company's stock price closed at NT$27.4 on the TSE on Thursday, February 22, 2018.
    The company has reported consolidated revenues of NT$155 million for January 2018, representing a 12.2% drop on month and 18% increase on year.
    For the third quarter of 2017, the company totaled NT$566 million in consolidated revenues, up 4.5% sequentially and up 31.8% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    23-Feb 41 39 1,125,800 27.30 27.65 27.30 27.50+0.10+0.36% 27.40 27.50
    22-Feb 108 72 2,942,250 26.80 27.50 26.80 27.40+0.60+2.24% 27.35 27.45
    21-Feb 95 69 2,553,571 26.80 26.85 26.80 26.80+0.20+0.75% 26.80 26.85
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Jan 2017 - Jan 2018 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Jan-18

    155

    (12.2%)

    18%

    155

    18%

    Dec-17

    177

    (2.2%)

    (12.7%)

    2,090

    5.1%

    Nov-17

    181

    16.5%

    8.6%

    1,913

    7.1%

    Oct-17

    155

    (7.4%)

    (0.7%)

    1,732

    6.9%

    Sep-17

    167

    (20.6%)

    22.2%

    1,577

    7.7%

    Aug-17

    211

    12.2%

    38%

    1,410

    6.2%

    Jul-17

    188

    6.4%

    34.3%

    1,199

    2.1%

    Jun-17

    176

    (11.9%)

    1%

    1,011

    (2.3%)

    May-17

    200

    20.9%

    16.4%

    835

    (2.9%)

    Apr-17

    166

    (17.5%)

    (7.7%)

    635

    (7.8%)

    Mar-17

    201

    46.7%

    13.5%

    469

    (7.8%)

    Feb-17

    137

    4.2%

    1.5%

    268

    (19.1%)

    Jan-17

    131

    (35%)

    (33.2%)

    131

    (33.2%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2018

    Apex: Consolidated revenues, 3Q16 - 3Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    3Q-17

    566

    4.5%

    31.8%

    1,577

    7.7%

    2Q-17

    542

    15.6%

    3%

    1,011

    (2.3%)

    1Q-17

    469

    (10.8%)

    (7.8%)

    469

    (7.8%)

    4Q-16

    526

    22.4%

    (0.8%)

    1,990

    (1.3%)

    3Q-16

    430

    (18.4%)

    2.8%

    1,465

    (1.5%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2018

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 3Q16 - 3Q17 (NT$k)

    Item

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    Current assets

    1,308,761

    1,338,039

    1,233,710

    1,268,131

    1,108,550

    Intangible assets

    446,802

    420,386

    415,497

    432,513

    445,656

    Non-current assets

    1,304,102

    1,317,025

    1,273,566

    1,322,918

    1,318,301

    Assets

    2,612,863

    2,655,064

    2,507,276

    2,591,049

    2,426,851

    Current liabilities

    718,649

    804,349

    678,421

    738,224

    869,126

    Non-current liabilities

    297,752

    296,389

    295,241

    294,782

    5,427

    Liabilities

    1,016,401

    1,100,738

    973,662

    1,033,006

    874,553

    Stockholders' equity

    1,596,462

    1,554,326

    1,533,614

    1,558,043

    1,552,298

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2018

    Apex: Consolidated income statement, 3Q16 - 3Q17 (NT$k)

    Item

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

     

     

    469,035

     

    0

     

     

     

    Operating revenue

    566,344

    120.7%

    542,086

    115.6%

    469,035

    100%

    525,757

     

    429,703

    75.9%

    Gross profit (loss) from operations

    235,788

    50.3%

    246,958

    52.7%

    211,420

    45.1%

    217,533

    41.4%

    192,185

    33.9%

    Operating expenses

    196,531

    41.9%

    182,293

    38.9%

    170,935

    36.4%

    188,896

    35.9%

    167,287

    29.5%

    Operating income (loss)

    39,257

    8.4%

    64,665

    13.8%

    40,485

    8.6%

    28,637

    5.4%

    24,898

    4.4%

    Non-operating expenses and losses

    1,814

    0.4%

    -3,328

    -0.7%

    -3,882

    -0.8%

    -8,381

    -1.6%

    3,988

    0.7%

    Income from continuing operations before income tax

    41,071

    8.8%

    61,337

    13.1%

    36,603

    7.8%

    20,256

    3.9%

    28,886

    5.1%

    Net income (loss)

    22,938

    4.9%

    48,498

    10.3%

    26,213

    5.6%

    15,624

    3%

    26,264

    4.6%

    Diluted earnings per share (NT$)

    0.3

     

    0.5

     

    0.3

     

    0.2

     

    0.3

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2018

  • APEX Medical full profile

China smartphone AP shipments – 4Q 2017

Taiwan LCD TVs – 4Q 2017

Global tablet market – 4Q 2017

Taiwan server shipment forecast and industry analysis, 2018

China AMOLED panel capacity expansion forecast, 2016-2020

Taiwan server shipment forecast and industry analysis, 2017

© DIGITIMES Inc. All rights reserved.
Please do not republish, publicly broadcast or publicly transmit content from this website without written permission from DIGITIMES Inc. Please contact us if you have any questions.